Edition:
United Kingdom

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

73.04USD
16 Oct 2018
Change (% chg)

$-0.02 (-0.03%)
Prev Close
$73.06
Open
$73.54
Day's High
$73.57
Day's Low
$72.88
Volume
147,296
Avg. Vol
1,589,308
52-wk High
$83.87
52-wk Low
$60.15

Chart for

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $78,194.16
Shares Outstanding(Mil.): 1,016.57
Dividend: 0.50
Yield (%): 2.60

Financials

  CVS.N Industry Sector
P/E (TTM): 15.33 28.24 32.69
EPS (TTM): 5.02 -- --
ROI: 8.05 6.94 14.32
ROE: 15.36 11.02 16.04

Deals of the day-Mergers and acquisitions

Oct 10 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

10 Oct 2018

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

10 Oct 2018

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

10 Oct 2018

UPDATE 3-CVS, Aetna win U.S. approval for $69 bln deal

WASHINGTON/NEW YORK, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers.

10 Oct 2018

CVS, Aetna win approval for merger

WASHINGTON, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination the companies say can help cut soaring U.S. healthcare costs.

10 Oct 2018

U.S. Justice Dept expected to approve CVS deal for Aetna as soon as Wed - source

WASHINGTON, Oct 10 The U.S. Justice Department is expected to approve drug retailer CVS Health Corp's deal to buy health insurer Aetna Inc as soon as Wednesday, a source familiar with the review said.

10 Oct 2018

Aetna, seeking antitrust nod, sells Medicare drug business to WellCare

Health insurer Aetna Inc said on Thursday it will sell its standalone Medicare prescription drug plan business to WellCare Health Plans Inc as it seeks U.S. antitrust approval for a planned acquisition by CVS Health Corp .

27 Sep 2018

UPDATE 3-Aetna, seeking antitrust nod, sells Medicare drug business to WellCare

Sept 27 Health insurer Aetna Inc said on Thursday it will sell its standalone Medicare prescription drug plan business to WellCare Health Plans Inc as it seeks U.S. antitrust approval for a planned acquisition by CVS Health Corp.

27 Sep 2018

U.S. review of CVS deal for Aetna may end soon: source

WASHINGTON The U.S. Justice Department's antitrust review of CVS Health Corp's planned purchase of Aetna Inc may conclude soon, a source familiar with the review said on Monday.

17 Sep 2018

U.S. review of CVS deal for Aetna may end soon -source

WASHINGTON, Sept 17 The U.S. Justice Department's antitrust review of CVS Health Corp's planned purchase of Aetna Inc may conclude soon, a source familiar with the review said on Monday.

17 Sep 2018

Competitors

Earnings vs. Estimates